C‐myc expression in CD117(c‐kit)‐negative fractions of NK cells from all cancer patients was similar to its expression in CD117(c‐kit)‐positive fractions; therefore, c‐myc expression was assessed in the total NK cell populations. This evidence concerns the gene KIT and cancer.